UW Psychiatry Grand Rounds | John Ewing, MD
2024-10-25 12:00 - 13:00 (America/Chicago) | WisPIC, 6001 Research Park Blvd, Madison, WI, 53719
“Clinical Management of Opiate Use Disorder using: Medication, Therapeutic Neuroscience Education, and brief CBT”
WisPIC Commons Room
6001 Research Park Blvd in Madison, WI
+ Virtual Event – via WebEx
UW Psychiatry Grand Rounds | John Ewing, MD
“Clinical Management of Opiate Use Disorder using: Medication, Therapeutic Neuroscience Education, and brief CBT”

Learning Objectives:

Reading List:

Dorsal hippocampus to nucleus accumbens projections drive reinforcement via activation of accumbal dynorphin neurons
A review of the kappa opioid receptor system in opioid use
Addiction science: Uncovering neurobiological complexity
The Kappa-Opiate Receptor Impacts the Pathophysiology and Behavior of Substance Use

About the Speaker:

Webex Info:

American Medical Association (AMA) The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC) The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1.0 ANCC contact hours.
American Psychological Association (APA) Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsi-bility for the content of the programs.
Continuing Education Units Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
Continuing Education Units. The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Educa-tion Association (UPCEA), authorizes this program for 0.125 continuing education units (CEUs) or 1.25 hours.

Educational Conference: Ketty Thertus, MD & Neeta Shenai, MD
2024-12-18 12:00 - 13:00
Speakers: Ketty Thertus, MD and Neeta Shenai, MD

Title:
Location: WebEx

Learning Objectives:

About the Speakers:

About the Series:
The Educational Conference series is a series of lectures designed to provide clinically useful information to the practicing psychiatrist (faculty or trainee). Every 1 to 2 months an intra- or extra-departmental speaker is invited to speak on a topic of interest selected by current faculty. This educational series is open to the public and anyone is welcome to attend. Continue Medical Education units (CME’s) are available to eligible attendees.
Accreditation Statement
In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Designation Statements
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Psychological Association (APA)
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
Continuing Education Units
The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.1 continuing education units (CEUs) or 1 hour.

Grand Rounds: Candice Monson, PhD "Cognitive Processing Therapy for PTSD: The Latest Updates and Innovations"
2025-04-11 12:15 - 13:15 | WisPIC, 6001 Research Park Blvd, Madison, WI, 53719

30th Annual Wisconsin Symposium on Emotion
2025-04-16 - 2025-04-17 | Discovery Building – H.F. DeLuca Forum, 330 N ORCHARD ST, Madison, WI, 53715

Grand Rounds with Dr. Sarah Bowen | “A Mindfulness-Based Approach to Understanding and Treating Addictive Behaviors”
2025-05-30 12:15 - 13:15
Hybrid Event – WisPIC 6001 Research Park Blvd, Madison WI 53719, Commons Room 1616 or Virtual
Light refreshments will be provided from 12:00-12:15pm and the presentation will run from 12:15-1:15pm.

Biography:

Sarah Bowen, Ph.D. is a clinical psychologist. She is an Associate Professor at Pacific University, in Portland, OR, and affiliate research faculty in the Department of Psychiatry and Behavioral Sciences at the University of Washington in Seattle. She received her doctoral training under the mentorship of Dr. Alan Marlatt at University of Washington. Dr. Bowen’s research focuses primarily on mindfulness-based therapies for relapse prevention, with specific focus on mechanisms of change, including negative affect, thought suppression and craving. She has authored numerous articles and book chapters on this and related topics (see publications), and is lead au​thor of the Mindfulness-Based Relapse Prevention for Addictive Behaviors: A Clinician’s Guide. Dr. Bowen has facilitated MBRP groups in private and county treatment agencies, in criminal justice institutions, and at the VA Medical Center, and offers trainings to researchers and clinicians in the U.S., Europe, and Central America. She is particularly interested in the application of mindfulness-based work to dual-diagnosis and under-served populations.

Related Articles:
Bowen et al JAMA 2014
Roos Bowen Witkiewitz JCCP 2017-1
Witkiewitz and Bowen JCCP 2010
Virtual Attendance Information:

Join link: https://uwmadison.webex.com/uwmadison/j.php?MTID=m7f43a227d101b67cfe79cbe68f156bfa
Webinar number: 2866 753 6910
Webinar password: [REDACTED] (26936 when dialing from a phone or video system)
Join by phone
+1-415-655-0001 US Toll
+1-312-535-8110 United States Toll (Chicago)
Access code: 286 675 36910

Grand Rounds| Dr. Charles B. Nemeroff | “The Status of Laboratory Testing to Predict Antidepressant Response: Problems and Promises”
2026-01-23 12:00 - 13:15
Hybrid Event – WisPIC 6001 Research Park Blvd, Madison WI 53719, Commons Room 1616 or Virtual
Light refreshments will be provided from 12:00-12:15pm and the presentation will run from 12:15-1:15pm.

About the Speaker:

Charles B. Nemeroff, MD, PhD is Professor and Chair of the Department of Psychiatry and Behavioral Sciences at the Dell Medical School, University of Texas at Austin. He also directs the Institute for Early Life Adversity Research within the department as part of the Mulva Clinic for the Neurosciences, and co-directs the Center for Psychedelic Research and Therapy. Prior to joining Dell Med, Dr. Nemeroff was chair of the Department of Psychiatry and Behavioral Sciences and clinical director of the Center on Aging at the University of Miami Miller School of Medicine in Miami, Florida. He received his medical degree and doctorate degrees in neurobiology from the University of North Carolina (UNC) School of Medicine.
Dr. Nemeroff has received a number of research and education awards including the Mrazek Award in Psychiatric Pharmacogenomics, Kempf Award in Psychobiology, the Samuel Hibbs Award, Research Mentoring Award, Judson Marmor Award and the Vestermark Award from the American Psychiatric Association (APA), the Mood Disorders Award, Bowis Award and Dean Award from the ACP and the Julius Axelrod Award for mentoring from the ACNP. He was elected to the National Academy of Medicine in 2002. He was also named Alumnus of the Year from the University of North Carolina and from the UNC Medical School. He received the Doctorate Honoris Causa from Maimonides University in Buenos Aires in 2015 and a Professor Honoris Causa from Favaloro University in Buenos Aires in 2021.
Dr. Nemeroff is a member of the APA Council on Research and Chairs both the APA Research Colloquium for Young Investigators and the APA Work Group on Biomarkers and Novel Treatments. His research is focused on the pathophysiology of mood and anxiety disorders with a focus on the role of child abuse and neglect as a major risk factor. He has also conducted research on the role of mood disorders as a risk factor for major medical disorders including heart disease, diabetes and cancer. He has published more than 1,200 research reports and reviews, and his research is currently supported by grants from the National Institutes of Health.
Dr. Nemeroff has also served on the Mental Health Advisory Council of National Institute of Mental Health and the Biomedical Research Council for NASA; is co-editor in chief (with Alan F. Schatzberg, MD) of the Textbook of Psychopharmacology, published by the APA Press and now in its Fifth Edition; and is the co-editor in chief of a new journal published by Elsevier, Personalized Medicine in Psychiatry. He is the past President of the Anxiety and Depression Association of America (ADAA).

Related Articles:
Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study
Randomized, controlled, participant‐ and rater‐blind trial of pharmacogenomic test‐guided treatment versus treatment as usual for major depressive disorder

Grand Rounds | Dr. Chardée A. Galán
2026-05-08 12:00 - 13:15
